Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
AVROBIO, Inc. (AVRO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/24/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/14/2023 144 Form 144 - Report of proposed sale of securities:
07/12/2023 8-K Quarterly results
06/12/2023 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Departure of Directors or...
Docs: "Unaudited pro forma condensed combined financial information of AVROBIO, Inc. (giving effect to the Asset Sale) as of and for the three months ended March 31, 2023 and for the year ended December 31, 2022 and the notes related thereto",
"AVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 Million"
06/09/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/07/2023 144 Form 144 - Report of proposed sale of securities:
06/06/2023 SC 13G TANG CAPITAL PARTNERS LP reports a 6.1% stake in AVROBIO, Inc.
05/25/2023 144 Form 144 - Report of proposed sale of securities:
05/24/2023 144 Form 144 - Report of proposed sale of securities:
05/24/2023 144 Form 144 - Report of proposed sale of securities:
05/24/2023 144 Form 144 - Report of proposed sale of securities:
05/18/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis at the ASGCT 26 th Annual Meeting",
"AVROBIO, Inc. slide presentation"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update"
05/05/2023 ARS Form ARS - Annual Report to Security Holders:
05/01/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/01/2023 8-K Quarterly results
03/23/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/23/2023 10-K Annual Report for the period ended December 31, 2022
03/23/2023 8-K Quarterly results
Docs: "AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update"
02/27/2023 8-K Other Events  Interactive Data
01/19/2023 SC 13G/A GMT CAPITAL CORP reports a 7.6% stake in Avrobio, Inc.
12/07/2022 8-K Quarterly results
11/08/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
Docs: "Provides Business Update"
10/07/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/09/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/09/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/09/2022 8-K Quarterly results
07/29/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/29/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy